NCT00404339View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2014

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

mutant p53 peptide pulsed dendritic cell vaccine

BIOLOGICAL

tetanus toxoid helper peptide

PROCEDURE

adjuvant therapy

Trial Locations (1)

15232

UPMC Cancer Centers, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Robert Ferris

OTHER

NCT00404339 - Vaccine Therapy in Treating Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter